p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Modern Pathology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.3800488PMID 16258510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phyllodes tumors of the breast: the role of pathologic parameters.

  2005cited by this paper
• Initial Experience with Tissue Microarray in a Surgical Pathology Laboratory: Technical Considerations

  2004cited by this paper
• Prognostic Evaluation of Proliferative Activity and DNA Content in the Phyllodes Tumor of the Breast: Immunohistochemical and Flow Cytometric Study of 118 Cases

  2004cited by this paper
• Tissue microarrays: a current medical research tool

  2004cited by this paper
• c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?

  2004cited by this paper
• Oncogenic protein tyrosine kinases

  2004cited by this paper
• Kit as a human oncogenic tyrosine kinase.

  2004cited by this paper
• Reliability of Tissue Microarrays in Detecting Protein Expression and Gene Amplification in Breast Cancer

  2003cited by this paper
• Tumour Angiogenesis and p53 Protein Expression in Mammary Phyllodes Tumors

  2003cited by this paper
• Validating immunohistochemical staining for KIT (CD117).

  2003cited by this paper
• Malignant phyllodes tumours show stromal overexpression of c‐myc and c‐kit

  2003cited by this paper
• Increased p53 Protein Expression in Malignant Mammary Phyllodes Tumors

  2002cited by this paper
• Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay

  2002cited by this paper
• Immunohistochemical Profile of Cystosarcoma Phyllodes of the Breast: A Study of 23 Cases

  2002cited by this paper
• p53 protein expression and gene mutation in phyllodes tumors of the breast.

  2001cited by this paper
• Pathologic, Immunohistochemical, and Molecular Features of Benign and Malignant Phyllodes Tumors of the Breast

  2001cited by this paper
• CD34, CD117, and actin expression in phyllodes tumor of the breast.

  2000cited by this paper
• Primary treatment of cystosarcoma phyllodes of the breast

  2000cited by this paper
• Cytogenetics, Immunostaining for Fibroblast Growth Factors, p53 Sequencing, and Clinical Features of Two Cases of Cystosarcoma Phyllodes

  2000cited by this paper
• Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.

  2000cited by this paper
• Immunohistochemical expression of p53 protein in invasive breast carcinoma: clinicopathologic correlations.

  1999cited by this paper
• Malignant phyllodes tumours of the breast display increased stromal p53 protein expression

  1999cited by this paper
• Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast

  1999cited by this paper
• Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors

  1999cited by this paper
• p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome

  1999cited by this paper
• Cystosarcoma phyllodes of the breast: prognostic significance of proliferation and apoptosis associated genes.

  1999cited by this paper
• Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages

  1996cited by this paper
• The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 170 cases

  1996cited by this paper
• Fibroadenoma and Phyllodes Tumor

  1995cited by this paper
• Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases

  1995cited by this paper
• Malignant phyllodes tumours of the breast. A clinical and pathological analysis of 55 cases.

  1993cited by this paper
• The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes

  1992cited by this paper
• Which therapy for unexpected phyllode tumour of the breast?

  1992cited by this paper
• Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients.

  1992cited by this paper
• Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients

  1991cited by this paper
• Cystosarcoma phyllodes. A clinicopathologic analysis of 42 cases

  1978cited by this paper

• CCL19 and CCR6 as diagnostic biomarkers for differentiating phyllodes tumors from breast fibroadenomas: a machine learning-driven approach integrating EMT biology.

  2026cites this paper
• Fibroepithelial Lesions: An Update for Daily Practice (Part-I).

  2025cites this paper
• Borderline Phyllodes Breast Tumors: A Comprehensive Review of Recurrence, Histopathological Characteristics, and Treatment Modalities

  2025cites this paper
• A Comparative Study on Copy Number Variation in Subtypes of Breast Phyllodes Tumors

  2025cites this paper
• Case report: The first case of concurrent breast myeloid sarcoma and borderline phyllodes tumor with malignant features

  2024cites this paper
• Gene Expression Profiling of Fibroepithelial Lesions of the Breast

  2023cites this paper
• Prognostic factors of breast phyllodes tumors.

  2023cites this paper
• Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study

  2023cites this paper
• Co expression of EGFR and CD10 in patients with phyllodes tumors of the breast: a single center experience in North Western Algeria

  2023cites this paper
• "Growing fibroadenoma": Are there clinical and pathological features predicting a phyllodes tumor on surgical excision?

  2022cites this paper
• High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates.

  2022cites this paper
• Malignant phyllodes tumor of the breast: a systematic review

  2022cites this paper
• Fibroepithelial Lesions of the Breast.

  2022cites this paper
• Phyllodes Tumors: A Scoping Review of the Literature

  2021cites this paper
• Updates on Lobular Neoplasms, Papillary, Adenomyoepithelial, and Fibroepithelial Lesions of the Breast.

  2021cites this paper
• Giant Benign Mammary Phyllodes Tumor: Report of a Case and Review of the Literature

  2021cites this paper
• Skin-Reducing Mastectomy and Immediate Reconstruction for a Large Recurrent Borderline Phyllodes Tumor

  2021cites this paper
• KIF21A regulates breast cancer aggressiveness and is prognostic of patient survival and tumor recurrence

  2021cites this paper
• Fibroepithelial lesions revisited: implications for diagnosis and management

  2020cites this paper
• Accuracy of p53 and ki-67 in the graduation of phyllodes tumor, a model for practical application

  2020influential citation
• The Relation between Exon Variations of KIT Gene and Clinical Pathological Factors of Breast Cancer

  2020cites this paper
• Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study

  2020cites this paper
• Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast

  2019cites this paper
• Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade

  2019influential citation
• Fibroepithelial Lesions (Phyllodes Tumor and Fibroadenoma) of the Breast

  2019cites this paper
• Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features

  2019cites this paper
• Sarcoma of the Breast

  2018cites this paper
• Malignant transformation of phyllodes tumor: a case report and review of literature

  2018influential citation
• C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients

  2017cites this paper
• Tryptase expression as a prognostic marker in patients with resected gastric cancer

  2017cites this paper
• A Diagnostic Approach to Fibroepithelial Breast Lesions.

  2017cites this paper
• In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features

  2016cites this paper
• Phyllodes tumours of the breast: a consensus review

  2016cites this paper
• Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment

  2016cites this paper
• Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.

  2016cites this paper
• Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression

  2016cites this paper
• Molecular Pathology of Fibroepithelial Neoplasms of the Breast

  2015cites this paper
• Role of CD10 Immunoshistochemical Expression in Discriminating the Categories of Phylloides Tumor

  2015cites this paper
• Expression of mutant p 53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy

  2015cites this paper
• CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival

  2015cites this paper
• TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast

  2015cites this paper
• Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing

  2015cites this paper
• Frequent MED12 mutations in phyllodes tumours of the breast

  2015cites this paper
• Role of CD10 Immunohistochemical Expression in Predicting Aggressive Behavior of Phylloides Tumors.

  2015cites this paper
• Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy.

  2015cites this paper
• Aberrant expressions of c-KIT and DOG-1 in mucinous and nonmucinous colorectal carcinomas and relation to clinicopathologic features and prognosis.

  2015cites this paper
• Associations of epithelial c-kit expression in phyllodes tumours of the breast

  2015cites this paper
• C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast

  2015cites this paper
• Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms.

  2014cites this paper
• PHYLLOIDES TUMOR OF THE PROSTATE: A REVIEW OF LITERATURE AND A CASE REPORT

  2014cites this paper
• C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast

  2014cites this paper
• Biomarkers Distinguishing Mammary Fibroepithelial Neoplasms: A Tissue Microarray Study

  2014cites this paper
• Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells

  2014cites this paper
• Utility of Ki-67, CD10, CD34, p53, CD117, and Mast Cell Content in the Differential Diagnosis of Cellular Fibroadenomas and in the Classification of Phyllodes Tumors of the Breast

  2014cites this paper
• Application of immunohistochemistry in breast pathology: a review and update.

  2014cites this paper
• Immunohistochemical Expression of C-Kit in Fibroepithelial Tumors of Breast

  2013cites this paper
• Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.

  2013cites this paper
• Recent insights into the molecular pathogenesis of mammary phyllodes tumours

  2013cites this paper
• Analysis of phyllodes tumor recurrence according to the histologic grade

  2013cites this paper
• Tumors of the Breast

  2013cites this paper
• Stromal Matrix Metalloproteinase-14 Expression Correlates With the Grade and Biological Behavior of Mammary Phyllodes Tumors

  2012cites this paper
• Phyllodes tumor in the breast

  2012cites this paper
• E-cadherin expression in the epithelial components of mammary phyllodes tumors.

  2012cites this paper
• Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification

  2012cites this paper
• Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions

  2012cites this paper
• Fibroepithelial Lesions, Including Fibroadenoma and Phyllodes Tumors

  2011cites this paper
• Immunohistochemical and Molecular Markers in Breast Phyllodes Tumors

  2011cites this paper
• Expressão de CD44 e CD24 em carcinomas mamários ductais invasivos de acordo com análise dos subtipos moleculares e sua relação com fatores prognósticos

  2011cites this paper
• CD34, CD117, and Ki-67 Expression in Phyllodes Tumor of the Breast: An Immunohistochemical Study of 33 Cases

  2011cites this paper
• Phyllodes tumours of the breast – differentiating features in core needle biopsy

  2011cites this paper
• Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins

  2011cites this paper
• Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression

  2011cites this paper
• The significant role of mast cells in cancer

  2011cites this paper
• c-Kit expression and mutations in phyllodes tumors of the breast.

  2010cites this paper
• Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms

  2010cites this paper
• Phyllodes tumor of the breast: an update

  2010influential citation
• Mutation-Free Expression of c-Kit and PDGFRA in Phyllodes Tumors of the Breast

  2010influential citation
• Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival

  2010cites this paper
• Malignant phyllodes tumor composed almost exclusively of a fibrosarcomatous component: a case report and review of malignant phyllodes tumors with metastases

  2010cites this paper
• Pièges diagnostiques en pathologie mammaire. Cas no 3. Tumeur de nature fibroépithéliale à stroma hypercellulaire faisant évoquer une tumeur phyllode

  2009cites this paper
• Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours

  2009cites this paper
• Evidence for Transformation of Fibroadenoma of the Breast to Malignant Phyllodes Tumor

  2009cites this paper
• [Diagnostic pitfalls in mammary pathology. Case 3. Fibroepithelial tumor with hypercellular stroma, suggestive of phyllodes tumor].

  2009cites this paper
• Molecular pathogenesis of progression and recurrence in breast phyllodes tumors.

  2009influential citation
• The role of immunohistochemistry in the differential diagnosis of breast lesions.

  2009cites this paper
• Borderline and malignant phyllodes tumors display similar promoter methylation profiles

  2009cites this paper
• Update on Fibroepithelial Lesions of the Breast.

  2009cites this paper
• Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors

  2009cites this paper
• Recurrent challenges in the evaluation of fibroepithelial lesions.

  2009cites this paper
• Increased expression of non-sulfated chondroitin correlates with adverse clinicopathological parameters in prostate cancer

  2008cites this paper
• Immunohistochemical Phenotypes of Phyllodes Tumor of the Breast

  2008cites this paper
• A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra‐tumoral genetic heterogeneity and new genetic changes on recurrence

  2008cites this paper
• Stromal and epithelial cells react differentially to c-kit in fibroepithelial tumors of the breast.

  2008cites this paper
• Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon

  2008cites this paper
• Phyllodes Tumors of the Breast: The Role of Immunohistochemistry in Diagnosis

  2008influential citation
• Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate

  2007cites this paper
• p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray studyTan P-H, Jayabaskar T, Yip G, et al (Singapore Gen Hosp; Natl Kidney Foundation, Singapore; Natl Univ of Singapore) Mod Pathol 18:1527–1534, 2005§

  2007cites this paper
• Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast

  2007cites this paper
• c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases.

  2007cites this paper
• Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors

  2006cites this paper